During the past decade, Ospedale Generale Prov. Boldrini conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale Generale Prov. Boldrini" are "Bladder Cancer" (1 trials), "Colorectal Cancer" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Ospedale Generale Prov. Boldrini" in a lesser frequency.

Most popular intervention types in "Ospedale Generale Prov. Boldrini" are "Drug" (3 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (2 trials), "cisplatin" (2 trials), "etoposide" (1 trials), "fluorouracil" (1 trials) and "gemcitabine hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Generale Prov. Boldrini" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Generale Prov. Boldrini". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ospedale Generale Prov. Boldrini, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Generale Prov. Boldrini, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".